NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research ChannelBioSpace Collaborative Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Averion International Corp. 

225 Turnpike Road

Southborough  Massachusetts  01772  U.S.A.
Phone: 508-597-6000 Fax: 508-597-5789


SEARCH JOBS
Averion International Corp. (Averion) is a global full-service clinical research organization with proven expertise in designing, performing and managing drug, biologic and medical device trials. Our clinical services support the full product development lifecycle, from first-in-man through regulatory approval and beyond. Averion has a powerful focus in the areas of Oncology, Cardiovascular Diseases and Medical Devices. The company operates in North America, South America, Europe, and the Asia/Pacific region.

Averion’s core competencies are in agency product registration support, site selection, project management, medical and site monitoring, data management, biometrics, pharmacovigilance, medical writing, and full clinical trial management services throughout the clinical trials lifecycle. The Company has supported approvals for products in many therapeutic areas including: oncology, cardiovascular diseases and medical devices.

Averion is committed to providing clients with critical thinking, customer service and quality deliverables. Our 25 years of experience allows us to optimize each investigational product's chance for success.

We are dedicated to ensuring that each clinical trial is executed to the highest possible standards. For companies worldwide, Averion is a trusted partner in clinical research.


 Key Statistics


Email: info@averionintl.com
Ownership:
Web Site: Averion International Corp.
Employees: 400
Symbol: AVRO.OB
 









 Company News
Averion International Corp. (AVRO.OB) Reports 2008 Fourth Quarter and Full Year Financial Results 3/31/2009 8:33:11 AM    More...
Averion International Corp. (AVRO.OB) Appoints Peter C. Gonze as Executive Vice President, Global Business Development 8/19/2008 8:30:16 AM    More...
Averion Inc. Reports 2008 First Quarter Financial Results 5/16/2008 10:54:16 AM    More...
Averion Inc. Chief Medical Officer - Dr. Gene Resnick - to Lead Session at New York Biotechnology Association 17th Annual Meeting 5/16/2008 10:44:12 AM    More...
Averion Inc. Reports 2007 Third Quarter Financial Results 11/15/2007 9:19:15 AM    More...
IT&E International Group Announces Executive Changes 9/8/2006 2:36:30 PM    More...
IT&E International And Averion Inc. Complete Merger To Create Averion International Corp. 8/7/2006 11:38:54 AM    More...
IT&E International Signs Agreement To Merge With Averion Inc. 7/6/2006 10:55:46 AM    More...
Averion Inc. Expands Operations To Europe And Names John Shillingford, PhD As President Of New Wholly-Owned Subsidiary Averion GmbH 5/23/2006 12:53:49 PM    More...
BioSpace, Inc. And Massachusetts Biotechnology Council, Inc. Unveil 2006 Genetown™ Campaign 12/14/2005 6:22:26 PM    More...
12